Tanvex BioPharma Inc (泰福生技), which focuses on supplying safe and affordable biosimilars, has obtained marketing approval in Canada for its TX01, a biosimilar of Neupogen (filgrastim), the company said yesterday.
Tanvex has signed contracts with Canada-based Mint Pharmaceuticals Inc authorizing the firm to sell TX01 in Canada, it said in a statement.
It is not known when sales of the drug would begin, as discussions with importers are required first and the COVID-19 pandemic might disrupt distribution, Tanvex said.
The prices for TX01 have yet to be decided, as the company still has to negotiate with private insurers, it said.
The gap between the prices of brand drugs and biosimilars is smaller than between brand drugs and generic drugs, as biosimilars require more research and development, and are more complex than generic drugs, Tanvex said.
Sales in Canada of Neupogen and its biosimilars reached more than C$100 million (US$80.68 million) in the 12 months to June, Tanvex said.
Amgen Inc’s Neupogen is used to treat chemotherapy-induced neutropenia and decreases the incidence of infection caused by febrile neutropenia, the company said.
Amgen filed a patent infringement claim against Tanvex in July 2019, but Tanvex reached an agreement with Amgen in March last year.
The company declined to reveal how much it agreed to pay Amgen.
“The expense was lower than the legal expenses if we had chosen to continue engaging in a lawsuit with Amgen,” a company official said by telephone yesterday.
Tanvex said obtaining approval in Canada has made it more confident of receiving approval from the US Food and Drug Administration (FDA), adding that it applied for a biologics license with the agency in October 2018.
The company expects to gain approval from the US FDA in the third quarter of next year, it said.
Tanvex’s cumulative revenue totaled NT$560,000 (US$19,989) for the first three quarters, up 86 percent from a year earlier.
For the first two quarters, it registered a net loss of NT$793 million, less than its net loss of NT$1.17 billion a year earlier, company data showed.
HORMUZ ISSUE: The US president said he expected crude prices to drop at the end of the war, which he called a ‘minor excursion’ that could continue ‘for a little while’ The United Arab Emirates (UAE) and Kuwait started reducing oil production, as the near-closure of the crucial Strait of Hormuz ripples through energy markets and affects global supply. Abu Dhabi National Oil Co (ADNOC) is “managing offshore production levels to address storage requirements,” the company said in a statement, without giving details. Kuwait Petroleum Corp said it was lowering production at its oil fields and refineries after “Iranian threats against safe passage of ships through the Strait of Hormuz.” The war in the Middle East has all but closed Hormuz, the narrow waterway linking the Persian Gulf to the open seas,
Apple Inc increased iPhone production in India by about 53 percent last year and now makes a quarter of its marquee devices there, reflecting the US company’s efforts to avoid tariffs on China. The company assembled about 55 million iPhones in India last year, up from 36 million a year earlier, people familiar with the matter said, asking not to be named because the numbers aren’t public. Apple makes about 220 million to 230 million iPhones a year globally, with India’s share of the total increasing rapidly. Apple has accelerated its expansion in the world’s most populous country in recent years, bolstered
RATIONING: The proposal would give the Trump administration ample leverage to negotiate investments in the US as it decides how many chips to give each country US officials are debating a new regulatory framework for exporting artificial intelligence (AI) chips and are considering requiring foreign nations to invest in US AI data centers or security guarantees as a condition for granting exports of 200,000 chips or more, according to a document seen by Reuters. The rules are not yet final and could change. They would be the first attempt to regulate the flow of AI chips to US allies and partners since US President Donald Trump’s administration said it rescinded its predecessor’s so-called AI diffusion rules. Those rules sought to keep a significant amount of AI
HEADWINDS: The company said it expects its computer business, as well as consumer electronics and communications segments to see revenue declines due to seasonality Pegatron Corp (和碩) yesterday said it aims to grow its artificial intelligence (AI) server revenue more than 10-fold this year from last year, driven by orders from neocloud solutions clients and large cloud service providers. The electronics manufacturing service provider said AI server revenue growth would be driven primarily by the Nvidia Corp GB300 server platform. Server shipments are expected to increase each quarter this year, with the second half likely to outperform the first half, it said. The AI server market is expected to broaden this year as more inference applications emerge, which would drive demand for system-on-chip, application-specific integrated circuits
RSS